Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.320
-0.030 (-1.28%)
At close: Aug 28, 2025, 4:00 PM
2.320
0.00 (0.00%)
After-hours: Aug 28, 2025, 4:10 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $45.40 million as of August 28, 2025. Its market cap has decreased by -48.36% in one year.
Market Cap
45.40M
Enterprise Value
28.27M
1-Year Change
-48.36%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $45.40M, a decrease of -27.37%. That is a compound annual growth rate of -5.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 45.79M | -34.02% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.09B |
| Johnson & Johnson | 425.77B |
| AbbVie | 367.55B |
| UnitedHealth Group | 275.22B |
| AstraZeneca | 248.07B |
| Novo Nordisk | 246.45B |
| Novartis AG | 245.68B |
| Abbott Laboratories | 228.80B |